ReviewKorean circulation journal2023
Percutaneous Transcatheter Closure of Congenital Ventricular Septal Defects.
Review in Korean circulation journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 20 citations in OpenAlex.
- Structural Heart Interventions in Women with Congenital Heart Disease.Current cardiology reports · 2026Review
- Catastrophic Pediatric Stroke Following Attempted Transcatheter Ventricular Septal Defect Closure.JACC. Case reports · 2026Article
- Percutaneous closure of native and residual ventricular septal defects using a diverse range of occluder devices: a single-centre experience.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2026Article
- Aortic regurgitation following transcatheter closure of perimembranous ventricular septal defect in children: risk factors and long-term outcomes.Cardiovascular intervention and therapeutics · 2026Article
- Modified Arteriovenous Loop Technique for Successful Antegrade Device Closure of Perimembranous Ventricular Septal Defects with Aortic Valve Prolapse-A Single-Center Experience.Pediatric cardiology · 2026Article
- Predictive value of intraoperative hemodynamics and heart rate variability for postoperative emergence quality in children undergoing transcatheter VSD closure.Journal of cardiothoracic surgery · 2026Article
- Long-Term Outcomes Following Transcatheter Closure of Small Perimembranous Ventricular Septal Defects.Pediatric cardiology · 2026Article
- The "Cairo Accord"- towards the eradication of RHD: revisited (2026).Frontiers in cardiovascular medicine · 2026Review
- Retrograde transcatheter closure of perimembranous and muscular ventricular septal defects in pediatric and adult patients: 12month outcomes in a case series of 60 patients from Iran.ARYA atherosclerosis · 2026Article
- Transcatheter Closure of Ventricular Septal Defects after Upfront Transvenous Antegrade Cannulation from the Right Ventricle.Pediatric cardiology · 2026Article
- Percutaneous closure of perimembranous and infundibular ventricular septal defects: single-center experience in 203 patients with medium- and long-term follow-up.International journal of cardiology. Congenital heart disease · 2025Article
- Treatment strategies and prognosis of complete left bundle branch block after transcatheter closure of ventricular septal defect in pediatrics.BMC cardiovascular disorders · 2025Article
- Successful percutaneous closure of ventricular septal defects associated with pulmonary hypertension using different atrial septal defect Occluders: A report of two cases.Journal of cardiology cases · 2025Article
- Transjugular approach percutaneous closure: a preferred solution for challenging surgical management of ventricular septal rupture.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2025Article
- Early experience with transcatheter ventricular septal defects closure with the KONAR-MF multifunctional occluder.Frontiers in pediatrics · 2025Article
- Hybrid approach: a prospective option for treating congenital heart defects in pediatric patients.Frontiers in cardiovascular medicine · 2025Review
- Transcatheter closure of perimembranous ventricular septal defects in elderly patients and risk factors of postoperative arrhythmias.Frontiers in cardiovascular medicine · 2025Article
- Antithrombotic Therapy Following Structural Heart Disease Interventions: Current Status and Future Directions.Reviews in cardiovascular medicine · 2024Review
- Transcatheter Embolization in Congenital Cardiovascular Malformations-Variable Use of Vascular Plugs.Cardiovascular therapeutics · 2024Observational
- Demonstrating an Adult Ventricular Septal Defect Using Non-obstructive General Angioscopy.Cureus · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ventricular septal defects (VSDs) are the most common kind of congenital heart disease and, if indicated, surgical closure has been accepted as a gold-standard treatment. However, as less-invasive methods are preferred, percutaneous device closure has been developed. After the first VSD closure was performed percutaneously by Lock in 1988, both techniques and devices have developed consistently. A perventricular approach for closure of muscular VSD in small patients and the closure of perimembranous VSD using off-label devices are key remarkable developments. Even though the Amplatzer membranous VSD occluder (Abbott) could not be approved for use due to the high complete atrioventricular conduction block rate, other new devices have shown good results for closure of perimembranous VSDs. However, the transcatheter technique is slightly complicated to perform, and concerns about conduction problems after VSD closure with devices remain. There have been a few reports demonstrating successful closure of subarterial-type VSDs with Amplatzer devices, but long-term issues involving aortic valve damage have not been explored yet. In conclusion, transcatheter VSD closure should be accepted as being as effective and safe as surgery but should only be performed by experienced persons and in specialized institutes because the procedure is complex and requires different techniques. To avoid serious complications, identifying appropriate patient candidates for device closure before the procedure is very important.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.